At the conclusion of this educational activity, the participant should be able to:
1) Understand FSGS and its recurrence risk in transplanted kidneys 
2) Describe how data from 7 large pediatric health centers in the USA was used to identify FSGS recurrence rates, risk factors, and treatment outcomes
3) Summarize patient features and treatment options associated with higher recurrence or partial/complete remission
4) Important finding: Only treatment with anti-CD20, CTLA4-Ig agents, or LDL-apheresis sessions were associated with complete remission.

Session date: 
10/16/2024 - 3:30pm to 4:30pm EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
  • 1.00 Nursing CEU

Please login or register to take this course.